Pioneering Cancer Diagnostics with Next-Generation Rapid Testing Solutions

At OncoFirm Diagnostics , we are revolutionizing cancer diagnostics through cutting-edge lateral flow assay (LFA) technology, specializing in rapid test development for early cancer detection. Our proprietary diagnostic solutions utilize various antigens, with highly specific biomarkers linked to cancer progression, to provide accurate, fast, and accessible screening tools.

Our Mission

To empower doctors, hospitals, clinics, and diagnostic laboratories with highly sensitive and reliable rapid cancer tests, enabling early detection, improved patient outcomes, and personalized treatment pathways.

Our Technology

Lateral Flow Assay (LFA) Platform: Enables cost-effective, point-of-care testing with rapid results in minutes, eliminating the need for complex laboratory infrastructure. Using highly specific biomarkers associated with multiple cancers, enhancing test sensitivity and early-stage cancer detection.

Non-Invasive & Scalable Solutions: Designed for oncology screening programs, hospital diagnostics, and research institutions focusing on cancer and infectious diseases.

Who We Serve?
Hospitals & Clinics – Streamlining cancer diagnostics for early intervention and treatment planning.
Doctors & Oncologists – Providing rapid and reliable screening tools to enhance patient care.
Diagnostic Laboratories – Delivering innovative assays for precise cancer biomarker detection.
Cancer Screening Programs – Supporting large-scale early detection initiatives to improve survival rates.
Oncology & Infectious Disease Research – Advancing biomarker research for new therapeutic discoveries.

Why Choose Us?
✅ Rapid Results: LFA-based tests provide results in under 15 minutes.
✅ Highly Sensitive & Specific: based assays enhance early-stage cancer detection.
✅ Easy-to-Use & Non-Invasive: Designed for point-of-care settings with minimal training required.
✅ Cost-Effective & Scalable: Ideal for large-scale screening programs and clinical applications.

At OncoFirm Diagnostics, we are committed to driving the future of cancer diagnostics with groundbreaking biomarker-based rapid testing. Our innovations empower healthcare providers with faster, more accurate, and accessible tools for early cancer detection, ensuring better patient outcomes and improved survival rates worldwide.

For partnerships and inquiries, contact us at: investor@oncofirmdiagnostics.com